2016

1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

   Neuropharmacology, Vol. 108, pp. 345-352

2. A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

   Journal of Neurology, Vol. 263, Núm. 7, pp. 1390-1400